What is SXTPW stock price today?

SXTPW (60 Degrees Pharmaceuticals, Inc.) stock is trading at $0.09 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is SXTPW stock going up or down today?

SXTPW stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SXTPW stock now?

The decision to buy SXTPW depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SXTPW a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SXTPW based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SXTPW stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SXTPW is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SXTPW's P/E ratio?

P/E ratio data for SXTPW will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SXTPW's market cap?

Visit our dashboard for SXTPW's current market capitalization and other key metrics.

What is SXTPW's price to book ratio?

Price-to-book ratio for SXTPW is available on our dashboard along with other valuation metrics.

Does SXTPW pay dividends?

SXTPW does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SXTPW's dividend yield?

SXTPW does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SXTPW stock a good long-term investment?

SXTPW's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SXTPW's revenue growth rate?

Revenue growth data for SXTPW is available on our dashboard with detailed financial statement analysis.

Profitability metrics for SXTPW are available on our dashboard with complete income statement analysis.

What are the risks of investing in SXTPW?

Key risks for SXTPW include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SXTPW compare to its competitors?

Compare SXTPW to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SXTPW's performance and positioning.

What is SXTPW's stock price target for 2026?

Our AI model provides price targets for SXTPW based on fundamental analysis: Bull case $0.12 (+30%), Base case $0.10 (+15%), Bear case $0.08 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about SXTPW?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SXTPW. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SXTPW's next earnings report?

SXTPW reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SXTPW - 60 Degrees Pharmaceuticals, Inc.

NYSE * Healthcare * Biotechnology

$0.09

+$0.00 (+0.00%)

About 60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

SXTPW Key Statistics

Market Cap

$0.00M

Employees

How SXTPW Compares to Peers

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

N/A

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
SXTPW(This stock)	$0.00	N/A	0%	0.0%	-
AMGNAmgen Inc	$187.71B	24.5	0%	0.2%	vs AMGN
GILDGilead Sciences	$173.48B	20.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.35B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.71B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$25.83B	20.0	-0%	0.1%	vs BIIB

Data Updated: April 17, 2026 at 12:57 PM EDT

Ready to invest in SXTPW?

Commission-free trading available. Affiliate links.

SXTPW Lician Score

10% confidence

6.0/10

Good

SXTPW has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates SXTPWacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

SXTPW Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for SXTPW

Dashboard

Enter a ticker to analyze